Latest Articles

Subject

Article Type

You have access
Preoperative evaluation of the lung resection candidate
Peter Mazzone, MD, MPH

Cleveland Clinic Journal of Medicine May 2012, 79 (5 e-suppl 1) S17-S22; DOI: https://doi.org/10.3949/ccjm.79.s2.04
You have access
Selection of chemotherapy for patients with advanced non–small cell lung cancer
Nathan A. Pennell, MD, PhD

Cleveland Clinic Journal of Medicine May 2012, 79 (5 e-suppl 1) S46-S50; DOI: https://doi.org/10.3949/ccjm.78.s2.10
You have access
Stereotactic body radiotherapy for stage I non–small cell lung cancer
Kevin Stephans, MD

Cleveland Clinic Journal of Medicine May 2012, 79 (5 e-suppl 1) S26-S31; DOI: https://doi.org/10.3949/ccjm.79.s2.06
You have access
The emerging role of palliative medicine in the treatment of lung cancer patients
Mellar P. Davis, MD, FCCP, FAAHPM

Cleveland Clinic Journal of Medicine May 2012, 79 (5 e-suppl 1) S51-S55; DOI: https://doi.org/10.3949/ccjm.79.s2.11
You have access
Personalizing patient care
Kathryn A. Teng, MD and Charis Eng, MD, PhD

Cleveland Clinic Journal of Medicine May 2012, 79 (5) 329-330; DOI: https://doi.org/10.3949/ccjm.79a.11074

Personalized health care has been anticipated for decades. Yet in its breadth and in the way we would like it to be practiced, it is still in its infancy.
You have access
Lung cancer screening: Examining the issues
Peter Mazzone, MD, MPH

Cleveland Clinic Journal of Medicine May 2012, 79 (5 e-suppl 1) S1-S6; DOI: https://doi.org/10.3949/ccjm.79.s2.01
You have access
Lung cancer screening: What to expect
Cleveland Clinic Journal of Medicine May 2012, 79 (5) 346;
You have access
The role of adjuvant chemotherapy in early-stage and locally advanced non–small cell lung cancer
Marc Shapiro, MD

Cleveland Clinic Journal of Medicine May 2012, 79 (5 e-suppl 1) S42-S45; DOI: https://doi.org/10.3949/ccjm.79.s2.09
You have access
Hyperpigmentation and hypotension
Khaldoon Shaheen, MD, Abdul Hamid Alraiyes, MD, Motaz Baibars, MD and M. Chadi Alraies, MD, FACP

Cleveland Clinic Journal of Medicine May 2012, 79 (5) 308-312; DOI: https://doi.org/10.3949/ccjm.79a.10187

A 65-year-old man presents after 2 months of weakness, dizziness, and blurred vision. What test should be ordered?
You have access
Personalized targeted therapy in advanced non–small cell lung cancer
Patrick C. Ma, MD, MS

Cleveland Clinic Journal of Medicine May 2012, 79 (5 e-suppl 1) S56-S60; DOI: https://doi.org/10.3949/ccjm.79.s2.12

Main menu

User menu

Search

Latest Articles

Pages

Navigate

Authors & Reviewers